Search Results - Arjun V. Balar

  • Showing 1 - 4 results of 4
Refine Results
  1. 1

    A unique case of protein-losing enteropathy in the setting of immune checkpoint inhibition case report by Ezra Bernstein, James Weinberger, Avi Baskin, Eesha Balar, Victor Adorno Febles, Arjun V. Balar

    Published in Current Problems in Cancer: Case Reports (2023-09-01)
    Get full text
    Article


  2. 2

    Pembrolizumab plus either epacadostat or placebo for cisplatin-ineligible urothelial carcinoma: results from the ECHO-307/KEYNOTE-672 study by Andrea Necchi, Michiel S. Van der Heijden, Dmytro Trukhin, Avivit Peer, Howard Gurney, Boris Y. Alekseev, Francis X. Parnis, Raya Leibowitz, Maria De Santis, Petros Grivas, Jason Clark, Mihaela Munteanu, Ritesh Kataria, Calvin Jia, Arjun V. Balar, Ronald de Wit

    Published in BMC Cancer (2024-07-01)
    Get full text
    Article


  3. 3

    Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of urothelial cancer by Gary D Steinberg, Neal Shore, Petros Grivas, Matthew D Galsky, Elizabeth R Plimack, Shilpa Gupta, Arjun V Balar, Peter C Black, Matthew T Campbell, Gail S Dykstra, Christoper J Hoimes, Lidia P Lopez, Joshua J Meeks, Jonathan E Rosenberg, Ashish M Kamat

    Published in Journal for ImmunoTherapy of Cancer (2021-07-01)
    Get full text
    Article


  4. 4

    Bempegaldesleukin plus nivolumab in first-line renal cell carcinoma: results from the PIVOT-02 study by Mario Sznol, Adi Diab, Jonathan Zalevsky, Ute Hoch, Mehmet A Bilen, Giovanni Grignani, Nizar M Tannir, Erika Puente, Arjun V Balar, Daniel C Cho, Arlene O Siefker-Radtke, Lily Tang, David Chien, Arkopal Choudhury, Danni Yu, Sue L Currie, Mary A Tagliaferri, Michael E Hurwitz

    Published in Journal for ImmunoTherapy of Cancer (2022-04-01)
    Get full text
    Article


Search Tools: